Xolair Articles

Novartis highlights clinical projects to turn around fortunes at its pharma

27 September 1999

More Euro pharma firms discuss plans for future growth at GS conference

24 June 1999

Novartis anti-IgE antibody cuts hay fever symptoms

17 May 1999

Novartis highlights four new products at annual results meeting

18 March 1999

Novartis to market 21 new drugs by 2002

25 January 1999

Showing 101-105 of 105 articles

Go to beginningPreviousNextGo to end